|
Status |
Public on Dec 03, 2013 |
Title |
DUCaP cells treated for 8 hours with EtOH, experiment 2 |
Sample type |
RNA |
|
|
Source name |
DUCaP
|
Organism |
Homo sapiens |
Characteristics |
treatment: EtOH date of experiment: 10.05.2010 timepoint: 8
|
Treatment protocol |
Cells were cultured in the absence (EtOH) or presence of 1nM R1881 for 8 and 24 hours, respectively.
|
Growth protocol |
Cells (LNCaP, VCaP, DuCaP) were grown on polylysine-coated (Sigma) petridishes in RPMI1640 supplemented with 10% charcoal-stripped FCS overnight.
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted using TRI-reagent (Sigma) according to the manufacturer`s protocol. After DNA digestion with DnaseI (Qiagen), RNA was purified using Rneasy kit (Qiagen).
|
Label |
biotin
|
Label protocol |
Target RNA was labeled by addition of biotin-linked deoxynucleotides with terminal deoxynucleotidyl transferase according to the manufacturer's (Affymetrix) protocols. Washing and staining was performed in an Affymetrix 450S fluidics station.
|
|
|
Hybridization protocol |
Target samples were hybridized to Human Gene 1.0 ST v1 microarrays according to the manufacturer's protocols in a Affymetrix hybridization oven.
|
Scan protocol |
Microarrays were scanned in an Affymetrix 3000 scanner.
|
Description |
DUCaP cells treated for 8 hours with EtOH, experiment 2
|
Data processing |
Raw data was preprocessed using the GCRMA method. For transcript probe set definition a custom CDF package based on a complete re-alignment of the probe sequences to the genome and transcriptome (Ensembl version 68) was used; details on http://bioinfo.i-med.ac.at.
|
|
|
Submission date |
Sep 17, 2013 |
Last update date |
Dec 04, 2013 |
Contact name |
Johannes Rainer |
E-mail(s) |
[email protected]
|
Organization name |
Eurac Researc
|
Department |
Institute for Biomedicine
|
Lab |
Biomedical Informatics
|
Street address |
Via A. Volta 21
|
City |
Bolzano |
ZIP/Postal code |
39100 |
Country |
Italy |
|
|
Platform ID |
GPL17737 |
Series (1) |
GSE50936 |
SOCS2 expression correlates with tumor malignancy, exerts growth promoting effects and is enhanced by androgens in prostate cancer |
|